The mutares Group (ISIN: DE000A0SMSH2) closed the first half of 2015 with significant organic growth in revenues and a clear increase in profitability. Today’s publication of mutares Group’s Interim Report 2015 will be accompanied by a conference call for analysts and investors. Albeit the deconsolidation of the portfolio companies CGVL and Suir Pharma, mutares has […]
STS Acoustics, a portfolio company of mutares AG developing and producing acoustic components for the automotive industry, continues its successful repositioning by setting up a new site in Poland. STS Acoustics develops and produces innovative solutions for acoustic and thermal insulation in the motor and passenger compartment of vehicles and operates out of three sites […]
The Interim Report 2015 of the mutares Group (ISIN: DE000A0SMSH2) will be published on September 17, 2015. We kindly invite you to a conference call (held in English) taking place on the same day at 2:30pm. Dr. Axel Geuer, CEO of mutares AG, will discuss the highlights of the first six months and will provide […]
The total NAV (net asset value) of the mutares Group currently amounts to EUR 351.2m or EUR 25.02 per share. Hence, the NAV exceeds the current market capitalization significantly by 28 percent. The regular publication of the NAV is part of intensified capital market communications. To further increase transparency for investors and analysts, today mutares […]
The mutares Group (ISIN: DE000A0SMSH2) closed H1-2015 with a considerable organic growth in revenues and a significant increase in profitability based on preliminary figures. Given the dynamic transaction activities in 2015, mutares is confident to achieve another record year. Despite the deconsolidation of two portfolio companies (CGVL and Suir Pharma) the mutares Group increased its […]